Cargando…
Pulmonary perfusion with oxygenated blood or custodiol HTK solution during cardiac surgery for postoperative pulmonary function in COPD patients: a trial protocol for the randomized, clinical, parallel group, assessor and data analyst blinded Pulmonary Protection Trial
BACKGROUND: Five to thirty percent of patients undergoing cardiac surgery present with chronic obstructive pulmonary disease (COPD) and have a 2- to 10-fold higher 30-day mortality risk. Cardiopulmonary bypass (CPB) creates a whole body systemic inflammatory response syndrome (SIRS) that could impai...
Autores principales: | Buggeskov, Katrine B, Wetterslev, Jørn, Secher, Niels H, Andersen, Lars W, Jonassen, Thomas, Steinbrüchel, Daniel A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576307/ https://www.ncbi.nlm.nih.gov/pubmed/23363494 http://dx.doi.org/10.1186/1745-6215-14-30 |
Ejemplares similares
-
Pulmonary artery perfusion versus no pulmonary perfusion during cardiopulmonary bypass in patients with COPD: a randomised clinical trial
por: Buggeskov, Katrine B, et al.
Publicado: (2016) -
Detailed statistical analysis plan for the pulmonary protection trial
por: Buggeskov, Katrine B, et al.
Publicado: (2014) -
Custodiol HTK versus Plegisol: in-vitro comparison with the use of immature (H9C2) and mature (HCM) cardiomyocytes cultures
por: Nowicki, Rafał, et al.
Publicado: (2022) -
Protective effect of HTK solution on postoperative pulmonary function in infants with CHD and PAH
por: Li, Jindong, et al.
Publicado: (2017) -
Correction: Protective effect of HTK solution on postoperative pulmonary function in infants with CHD and PAH
por: Li, Jindong, et al.
Publicado: (2018)